The Safety and Efficacy of an Oral Penicillin Challenge Program in Cancer Patients: A Multicenter Pilot Study

Antibiotic allergies are reported by up to 1 in 4 cancer patients, almost 50% of which are considered low risk and precede the cancer diagnosis. We demonstrate the successful and safe implementation of a pilot oral penicillin challenge program for cancer patients with low-risk penicillin allergies,...

Descripción completa

Detalles Bibliográficos
Autores principales: Trubiano, Jason A, Smibert, Olivia, Douglas, Abby, Devchand, Misha, Lambros, Belinda, Holmes, Natasha E, Chua, Kyra Y, Phillips, Elizabeth J, Slavin, Monica A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287673/
https://www.ncbi.nlm.nih.gov/pubmed/30547046
http://dx.doi.org/10.1093/ofid/ofy306
Descripción
Sumario:Antibiotic allergies are reported by up to 1 in 4 cancer patients, almost 50% of which are considered low risk and precede the cancer diagnosis. We demonstrate the successful and safe implementation of a pilot oral penicillin challenge program for cancer patients with low-risk penicillin allergies, increasing the use of penicillin and narrow-spectrum beta-lactams post-testing.

Ejemplares similares